COMPANY HISTORY

MISSION STATEMENT

Neurodegenerative disorders, in particular Alzheimer’s disease pose one of the biggest challenges to 21st Century society. Unless an effective, new approach is developed soon, estimated costs by 2030 will be $2 trillion in the USA alone, while the personal impact is incalculable.

However, the disruptive technology of Neuro-Bio Ltd is already suggesting the plausible possibility of two game-changing breakthroughs in the treatment of Alzheimer’s: (a) a blood biomarker with diagnostic and even prognostic potential and (b) an intranasally administered drug that could stabilise cell loss by combatting the pivotal toxin discovered by Neuro-Bio. Whilst either of these steps would amount to a real advance, (a) and (b) together would enable administration of an effective drug ideally at the pre-symptomatic stage: an effective cure.

Neuro-Bio Ltd
Building F5
Culham Science Centre
Abingdon
Oxfordshire
OX14 3DB
United Kingdom

(+44) 01235 420085

info@neuro-bio.com

© All Rights Reserved NeuroBio